Compounds > lofexidine
Page last updated: 2024-08-23

lofexidine and Acute Disease

lofexidine has been researched along with Acute Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, R; Farrell, M; Gowing, L; White, JM1
Ali, R; Gowing, L; Mbewe, D; White, JM1
Ali, R; Gowing, L; White, JM1

Reviews

3 review(s) available for lofexidine and Acute Disease

ArticleYear
Alphaâ‚‚-adrenergic agonists for the management of opioid withdrawal.
    The Cochrane database of systematic reviews, 2016, May-03, Issue:5

    Topics: Acute Disease; Adrenergic alpha-2 Receptor Agonists; Clonidine; Controlled Clinical Trials as Topic; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome

2016
Buprenorphine for managing opioid withdrawal.
    The Cochrane database of systematic reviews, 2017, 02-21, Volume: 2

    Topics: Acute Disease; Buprenorphine; Clonidine; Female; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome

2017
Buprenorphine for the management of opioid withdrawal.
    The Cochrane database of systematic reviews, 2009, Jul-08, Issue:3

    Topics: Acute Disease; Buprenorphine; Clonidine; Humans; Narcotic Antagonists; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome

2009